By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Developing innovative medicines in areas of high unmet need for cancer patients6.5M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States7M100.00%